-
71تقرير
المصدر: A Phase I/II Study of PXD101 in Patients With Unresectable Hepatocellular Carcinoma With Pharmacokinetic and Pharmacodynamic Evaluation
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00321594Test
-
72تقرير
المصدر: Phase II Study of Bevacizumab Plus Erlotinib in Patients With Advanced Hepatocellular Cancer (HCC)
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00365391Test
-
73تقرير
المصدر: Zhu AX, Ancukiewicz M, Supko JG, Sahani DV, Blaszkowsky LS, Meyerhardt JA, Abrams TA, McCleary NJ, Bhargava P, Muzikansky A, Sheehan S, Regan E, Vasudev E, Knowles M, Fuchs CS, Ryan DP, Jain RK, Duda DG. Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study. Clin Cancer Res. 2013 Mar 15;19(6):1557-66. doi: 10.1158/1078-0432.CCR-12-3041. Epub 2013 Jan 29.
A Phase II Study of AZD2171 in Hepatocellular Carcinomaالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00427973Test
Other URLs: http://www.ncbi.nlm.nih.gov/pubmed/23362324Test
-
74تقرير
المصدر: A Phase II Trial of Dasatinib (BMS-354825) in Advanced Hepatocellular Carcinoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00459108Test
-
75تقرير
المصدر: A Phase 2 Study of AZD6244 in Advanced or Metastatic Hepatocellular Carcinoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00604721Test
-
76تقرير
المصدر: A Phase 2 Study of IMC-A12 (NSC742460) in Hepatocellular Carcinoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00639509Test
-
77تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: The CapSul Trial: A Phase II Study of Sunitinib and Capecitabine for the Treatment of Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00787787Test
-
78تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: Phase I Adjuvant Trial of Sorafenib in Hepatocellular Carcinoma Patients After Liver Transplantation
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00844168Test
-
79تقرير
المصدر: Phase I/II Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00966251Test
-
80تقرير
المصدر: Downstaging of Hepatocellular Carcinoma by Stereotactic Body Radiotherapy for Non-Resectable and Non-Transplantable Tumors: Phase 2 Study
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01194206Test